Short cuts

Budget warning follows latest NICE drug approvals The National Institute for Clinical Excellence has approved the use of orlistat for obesity and pioglitazone for type-2 diabetes by the NHS in England and Wales. Orlistat may be prescribed to clinically obese adults who also have another serious illness such as high ...

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here